Clinical Trial Details
EORTC-30972
Back to Clinical Trials Database
RANDOMIZED PHASE III STUDY OF JM-216 ORAL PLATINUM PLUS PREDNISONE OR PREDNISONE ALONE IN PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 02-Jun-1998 Date Step1 close: 25-Jul-1999 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 380 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
